-
1
-
-
84969920110
-
Variability in pathologists' interpretations of individual breast biopsy slides: A population perspective
-
Elmore JG, Nelson HD, Pepe MS, Longton GM, Tosteson ANA, Geller B, et al. Variability in pathologists' interpretations of individual breast biopsy slides: a population perspective. Ann Intern Med. 2016;164:649-55. doi:10.7326/M15-0964
-
Ann Intern Med
, vol.2016
, Issue.164
, pp. 649-655
-
-
Elmore, J.G.1
Nelson, H.D.2
Pepe, M.S.3
Longton, G.M.4
Tosteson, A.N.A.5
Geller, B.6
-
2
-
-
84964695190
-
Rethinking the standard for ductal carcinoma in situ treatment [Editorial]
-
PMID: 26291410
-
Esserman L, Yau C. Rethinking the standard for ductal carcinoma in situ treatment [Editorial]. JAMA Oncol. 2015;1:881-3. [PMID: 26291410] doi:10.1001/jamaoncol.2015.2607
-
(2015)
JAMA Oncol
, vol.1
, pp. 881-883
-
-
Esserman, L.1
Yau, C.2
-
3
-
-
84925883647
-
Expertise vs evidence in assessment of breast biopsies: An atypical science [Editorial]
-
PMID: 25781438
-
Davidson NE, Rimm DL. Expertise vs evidence in assessment of breast biopsies: an atypical science [Editorial]. JAMA. 2015;313: 1109-10. [PMID: 25781438] doi:10.1001/jama.2015.1945
-
(2015)
JAMA
, vol.313
, pp. 1109-1110
-
-
Davidson, N.E.1
Rimm, D.L.2
-
4
-
-
84936744196
-
Discordant interpretations of breast biopsy specimens by pathologists [Letter]
-
PMID: 26151272
-
Leonard G. Discordant interpretations of breast biopsy specimens bypathologists [Letter].JAMA.2015;314:82-3. [PMID: 26151272] doi: 10.1001/jama.2015.6224
-
(2015)
JAMA
, vol.314
, pp. 82-83
-
-
Leonard, G.1
-
5
-
-
84969966046
-
-
National Public Radio. 26 July, on 29 February 2016
-
1430: The Andy Letter. Car Talk. National Public Radio. 26 July 2014. Accessed at www.cartalk.com/content/1430-andy-letter on 29 February 2016.
-
(2014)
1430: The Andy Letter. Car Talk
-
-
-
6
-
-
84936759993
-
Discordant interpretations of breast biopsy specimens by pathologists - reply [Letter]
-
PMID: 26151274
-
Elmore JG, Pepe MS, Weaver DL. Discordant interpretations of breast biopsy specimens by pathologists - reply [Letter]. JAMA. 2015;314:83-4. [PMID: 26151274] doi:10.1001/jama.2015.6239
-
(2015)
JAMA
, vol.314
, pp. 83-84
-
-
Elmore, J.G.1
Pepe, M.S.2
Weaver, D.L.3
-
7
-
-
84928824261
-
Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
-
PMID: 25502729
-
Sanders ME, Schuyler PA, Simpson JF, Page DL, Dupont WD. Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol. 2015;28:662-9. [PMID: 25502729] doi:10.1038/modpathol.2014.141
-
(2015)
Mod Pathol
, vol.28
, pp. 662-669
-
-
Sanders, M.E.1
Schuyler, P.A.2
Simpson, J.F.3
Page, D.L.4
Dupont, W.D.5
-
8
-
-
84939810960
-
Survival benefit of breast surgery for low-grade ductal carcinoma in situ: A population-based cohort study
-
PMID: 26039049
-
Sagara Y, Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT, et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg. 2015; 150:739-45. [PMID: 26039049] doi:10.1001/jamasurg.2015.0876
-
(2015)
JAMA Surg
, vol.150
, pp. 739-745
-
-
Sagara, Y.1
Mallory, M.A.2
Wong, S.3
Aydogan, F.4
DeSantis, S.5
Barry, W.T.6
-
9
-
-
84925807420
-
Tamoxifen for prevention of breast cancer: Extended long-term follow-up of the IBIS-I breast cancer prevention trial
-
PMID: 25497694
-
Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, et al; IBIS-I Investigators. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol. 2015;16:67-75. [PMID: 25497694] doi:10.1016/S1470-2045(14)71171-4
-
(2015)
Lancet Oncol
, vol.16
, pp. 67-75
-
-
Cuzick, J.1
Sestak, I.2
Cawthorn, S.3
Hamed, H.4
Holli, K.5
Howell, A.6
-
10
-
-
70350710119
-
Rethinking screening for breast cancer and prostate cancer
-
PMID: 19843904
-
Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302:1685-92. [PMID: 19843904] doi:10.1001/jama.2009.1498
-
(2009)
JAMA
, vol.302
, pp. 1685-1692
-
-
Esserman, L.1
Shieh, Y.2
Thompson, I.3
|